Montreal, Canada
Perceiv AI, founded in 2018 and headquartered in Canada, operates at the cutting-edge intersection of AI, Analytics, Health Care, and Pharmaceuticals, with a strong focus on Machine Learning applications. With the slogan "Transforming biopharma through intelligent patient selection. Making precision medicine a reality," Perceiv AI is committed to revolutionizing precision medicine by leveraging medical data and advanced deep learning capabilities.
The company aims to significantly enhance treatment efficacy by identifying patients who will most benefit from specific treatments, thus optimizing diagnosis and prognosis processes. Perceiv AI's platform is crucial in settings that demand precise decision-making, such as precision medicine and population enrichment for clinical trials.
In its latest funding round, a $1.50M Seed Round on 08 December 2022, Perceiv AI attracted investments from notable entities including StartUp Health, Investissement Québec, McKesson Ventures, Northpond Ventures, Red Abbey Venture Partners, Boreal Ventures, Merck Digital Sciences Studio, IKJ Capital, Center of Aging and Brain Health Innovation, and Plug and Play, demonstrating robust confidence in its technological promise and market potential.
